Related Experiment Video
Updated: May 23, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
PP2A inactivation is a crucial step in triggering apoptin-induced tumor-selective cell killing
R Zimmerman1, D J Peng, H Lanz
1Department of Molecular Genetics, Leiden Institute for Chemistry, Leiden University, Leiden, The Netherlands.
Abstract:
Apoptin (apoptosis-inducing protein) harbors tumor-selective characteristics making it a potential safe and effective anticancer agent. Apoptin becomes phosphorylated and induces apoptosis in a large panel of human tumor but not normal cells. Here, we used an in vitro oncogenic transformation assay to explore minimal cellular factors required for the activation of apoptin. Flag-apoptin was introduced into normal fibroblasts together with the transforming SV40 large T antigen (SV40 LT) and SV40 small t antigen (SV40 ST) antigens. We found that nuclear expression of SV40 ST in normal cells was sufficient to induce phosphorylation of apoptin. Mutational analysis showed that mutations disrupting the binding of ST to protein phosphatase 2A (PP2A) counteracted this effect. Knockdown of the ST-interacting PP2A-B56γ subunit in normal fibroblasts mimicked the effect of nuclear ST expression, resulting in induction of apoptin phosphorylation. The same effect was observed upon downregulation of the PP2A-B56δ subunit, which is targeted by protein kinase A (PKA). Apoptin interacts with the PKA-associating protein BCA3/AKIP1, and inhibition of PKA in tumor cells by treatment with H89 increased the phosphorylation of apoptin, whereas the PKA activator cAMP partially reduced it. We infer that inactivation of PP2A, in particular, of the B56γ and B56δ subunits is a crucial step in triggering apoptin-induced tumor-selective cell death.
Insights
Apoptin phosphorylation, crucial for tumor cell death, is triggered by inactivation of protein phosphatase 2A (PP2A) subunits. This discovery offers insights into developing safer, effective anticancer agents targeting tumor cells specifically.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Apoptin, an apoptosis-inducing protein, exhibits tumor-selective properties, suggesting its potential as a safe anticancer agent.
- Apoptin phosphorylation is essential for inducing apoptosis in tumor cells, but not in normal cells.
Purpose of the Study:
- To investigate the minimal cellular factors required for apoptin activation using an in vitro oncogenic transformation assay.
- To elucidate the role of SV40 antigens and associated cellular pathways in regulating apoptin phosphorylation and subsequent apoptosis.
Main Methods:
- Introduction of Flag-apoptin into normal fibroblasts with SV40 large T and small t antigens.
- Utilizing mutational analysis to assess the impact of SV40 small t antigen binding to protein phosphatase 2A (PP2A) on apoptin phosphorylation.
- Employing knockdown of PP2A subunits (B56γ and B56δ) and modulation of protein kinase A (PKA) activity to study their effects on apoptin phosphorylation.
Main Results:
- Nuclear expression of SV40 small t antigen in normal cells induced apoptin phosphorylation.
- Disruption of SV40 small t antigen binding to PP2A counteracted this phosphorylation.
- Knockdown of PP2A-B56γ or PP2A-B56δ subunits mimicked SV40 small t antigen effects, inducing apoptin phosphorylation.
- Inhibition of PKA increased apoptin phosphorylation in tumor cells, while PKA activation reduced it.
Conclusions:
- Inactivation of PP2A, particularly its B56γ and B56δ subunits, is a critical step in initiating apoptin-induced tumor-selective cell death.
- The interplay between PP2A, PKA, and SV40 antigens regulates apoptin activation, highlighting a potential therapeutic target for cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Negative Regulator Molecules

